Medication review at ICU to ward transfer cuts drug problems

Medication review at ICU to ward transfer cuts drug problems
(HealthDay)—Medication review by a clinical pharmacist and immediate communication of drug therapy recommendations can reduce the number of drug-related problems (DRPs) at the transfer point from intensive care unit (ICU) to ward, according to a study published online Aug. 12 in the Journal of Clinical Pharmacy and Therapeutics.

Annemie Heselmans, Ph.D., from KU Leuven in Belgium, and colleagues conducted a to assess the impact of assigning a clinical pharmacist to the transfer process from ICU to wards. The clinical pharmacist performed a medical review in both groups; in the , recommendations for drug therapy changes were immediately communicated, whereas they were kept blinded in the .

The researchers identified DRPs in the medical records of 60 percent of the 600 participants. Overall, 743 recommendations were made, 375 and 368 in the intervention and control groups, respectively; 24.8 percent were judged as major. A total of 54.1 versus 12.8 percent of these problems were adjusted on time in the intervention and control groups, respectively. The odds of implementing recommendations of drug therapy changes were higher in the implementation versus control group (odds ratio, 10.1), even after adjustment for between-group differences in types of DRPs (odds ratio, 15.6).

"The integration of a clinical pharmacist at the transfer point from ICU to ward led to a significant reduction in DRPs," the authors write.


Explore further

Physician/Pharmacist model can improve mean BP

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Medication review at ICU to ward transfer cuts drug problems (2015, August 23) retrieved 17 June 2019 from https://medicalxpress.com/news/2015-08-medication-icu-ward-drug-problems.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
86 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more